Ascendis Pharma A/S (ASND) vs Incyte Corporation (INCY)
- Ascendis Pharma A/S ASND 225.78 −0.37%
- Incyte Corporation INCY 112.95 −0.28%
Ascendis Pharma A/S and Incyte Corporation are both Biotechnology companies. Incyte Corporation is the larger, with a market value of $23.0B against $14.9B — 1.5× the size. Incyte Corporation trades at the lower P/E: 13.9× against 16.3×. Ascendis Pharma A/S grew revenue faster over the last twelve months: 126.0% against 26.9%. Ascendis Pharma A/S has the higher net margin (71.2% vs 27.7%) and the lower return on invested capital (15.1% vs 60.5%). Across the 21 metrics below, Incyte Corporation leads on 16 and Ascendis Pharma A/S on 5.
Valuation
Profitability
| Metric | ASND | INCY | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.26% | 92.62% | 65.16% |
| Operating margin | 24.84% | 30.56% | 0.00% |
| Net margin | 71.20% | 27.71% | 0.00% |
| Free cash flow margin | 31.97% | 32.48% | 0.00% |
| Return on equity | 118.44% | 30.67% | (56.36%) |
| Return on assets | 44.34% | 23.55% | (48.04%) |
| Return on invested capital | 15.07% | 60.50% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack